Contact
searchSearch
HMP Global
Kevin Chen, PharmD, MS, BCOP, CPP
Conference Coverage
Evolving Treatment Landscape of New and Novel Therapies for Solid Tumors
12/17/2025
Kevin Chen, PharmD, MS, BCOP
Kevin Chen, PharmD, discussed the increase in recent biomarker-driven drug approvals for solid tumors at the 2025 JADPRO Annual Conference, highlighting their targeted efficacy, unique toxicity profiles, and the need for clinicians to stay up...
Kevin Chen, PharmD, discussed the increase in recent biomarker-driven drug approvals for solid tumors at the 2025 JADPRO Annual Conference, highlighting their targeted efficacy, unique toxicity profiles, and the need for clinicians to stay up...
Kevin Chen, PharmD, discussed...
12/17/2025
Oncology Learning Network APP Institute
Shila Pandey, DNP, AGPCNP-BC, ACHPN, FPCN
Conference Coverage
Development of an APP-Led Quality Assurance Committee to Enhance Patient Safety and Care Quality
12/11/2025
Shila Pandey, DNP, AGPCNP-BC, ACHPN
At the 2025 JADPRO meeting, Shila Pandey, DNP, shared insights into the development of an advanced-practice-provider-led quality assurance committee designed to improve patient safety and care quality.
At the 2025 JADPRO meeting, Shila Pandey, DNP, shared insights into the development of an advanced-practice-provider-led quality assurance committee designed to improve patient safety and care quality.
At the 2025 JADPRO meeting,...
12/11/2025
Oncology Learning Network APP Institute
Danielle Roman, PharmD, BCOP
Conference Coverage
Evolving Treatments and Strategies for Triple-Positive Metastatic Breast Cancer: Integrating HER2 and Endocrine Therapies
12/11/2025
Danielle Roman, PharmD
Danielle Roman, PharmD, highlighted evolving treatment strategies for hormone receptor–positive, HER2-positive metastatic breast cancer, emphasizing the integration of HER2-targeted therapies, endocrine therapy, and emerging CDK4/6 inhibitors...
Danielle Roman, PharmD, highlighted evolving treatment strategies for hormone receptor–positive, HER2-positive metastatic breast cancer, emphasizing the integration of HER2-targeted therapies, endocrine therapy, and emerging CDK4/6 inhibitors...
Danielle Roman, PharmD,...
12/11/2025
Oncology Learning Network APP Institute
News
Integrated Clinical Pathway for Febrile Neutropenia Care Standardizes Treatment and Reduces Hospital Admissions Across Multi-Site Oncology Network
10/29/2025
Emily Estrada
According to data presented at the 2025 JADPRO Live meeting, an integrated clinical decision pathway for febrile neutropenia standardized care and reduced patient hospital admissions across a large cancer center network.
According to data presented at the 2025 JADPRO Live meeting, an integrated clinical decision pathway for febrile neutropenia standardized care and reduced patient hospital admissions across a large cancer center network.
According to data presented at...
10/29/2025
Oncology Learning Network APP Institute
News
Community Oncology APP Fellowship Improves Clinical Readiness and Oncology Specialty Provider Retention
10/29/2025
Emily Estrada
The implementation of an advanced practice provider fellowship improved clinical readiness and retention for new graduate nurse practitioners and physician assistants within oncology specialties in a large community oncology network.
The implementation of an advanced practice provider fellowship improved clinical readiness and retention for new graduate nurse practitioners and physician assistants within oncology specialties in a large community oncology network.
The implementation of an...
10/29/2025
Oncology Learning Network APP Institute
News
Integrated Clinical Pathway Improves Patient Access and Efficiency for Infusion Treatments Across Multi-Site Cancer Center Network
10/29/2025
Emily Estrada
A clinical decision pathway created by advanced practice provider leaders enabled patients to receive infusion treatments at alternative locations within a large, multi-site cancer center network.
A clinical decision pathway created by advanced practice provider leaders enabled patients to receive infusion treatments at alternative locations within a large, multi-site cancer center network.
A clinical decision pathway...
10/29/2025
Oncology Learning Network APP Institute
News
Electronic Medical Record Integrated Clinical Decision Pathway System Standardizes Care Across Multisite Cancer Center
10/29/2025
Emily Estrada
The implementation of electronic medical record-integrated clinical decision pathways improved workflow efficiency, dynamic responsiveness, and multidisciplinary collaboration across a large multisite oncology center.
The implementation of electronic medical record-integrated clinical decision pathways improved workflow efficiency, dynamic responsiveness, and multidisciplinary collaboration across a large multisite oncology center.
The implementation of electronic...
10/29/2025
Oncology Learning Network APP Institute
Christa Braun-Inglis, DNP, APRN, FNP-BC, AOCNP
Conference Coverage
Oncology Paired Preceptor Program Supports Nurse Practitioner Transition to Practice in Hawaii
11/27/2024
Christa Braun-Inglis, DNP, APRN, FNP-BC, AOCNP, assesses the effect implementing an academic-community partnership has on doctor of nursing students who are interested in oncology.
Christa Braun-Inglis, DNP, APRN, FNP-BC, AOCNP, assesses the effect implementing an academic-community partnership has on doctor of nursing students who are interested in oncology.
Christa Braun-Inglis, DNP, APRN,...
11/27/2024
Oncology Learning Network APP Institute
Conference Coverage
Advanced Practice Providers Play Pivotal Role in Delivering Cancer Screening Services and Follow-Up Care to Vulnerable Populations
11/21/2024
Gina Tomaine
Advanced practice providers play a unique role in delivering cancer screening services and follow-up care to vulnerable populations, emphasizing the importance of their expertise, accessibility, and patient-centered approach to improving...
Advanced practice providers play a unique role in delivering cancer screening services and follow-up care to vulnerable populations, emphasizing the importance of their expertise, accessibility, and patient-centered approach to improving...
Advanced practice providers play...
11/21/2024
Oncology Learning Network APP Institute
Dylana Smith, MS, AGPCNP-BC, HNP
Conference Coverage
Boosting Advanced Practice Provider Engagement at Memorial Sloan Kettering Cancer Center
11/21/2024
Dylana Smith, MS, AGPCNP-BC, HNP, discusses an initiative to boost APP engagement at Memorial Sloan Kettering Cancer Center and the growth of the program since its inception.
Dylana Smith, MS, AGPCNP-BC, HNP, discusses an initiative to boost APP engagement at Memorial Sloan Kettering Cancer Center and the growth of the program since its inception.
Dylana Smith, MS, AGPCNP-BC,...
11/21/2024
Oncology Learning Network APP Institute
Marlee Bogema, MSN, APRN, FNP-C
Conference Coverage
Outpatient Bispecific Program Demonstrates Safety and Tolerability in the Community Setting
11/21/2024
Marlee Bogema, MSN, APRN, FNP-C, discusses a protocol developed by a community oncology practice which demonstrated that outpatient administration of bispecific antibodies is both safe and well-tolerated and reduces the number of required...
Marlee Bogema, MSN, APRN, FNP-C, discusses a protocol developed by a community oncology practice which demonstrated that outpatient administration of bispecific antibodies is both safe and well-tolerated and reduces the number of required...
Marlee Bogema, MSN, APRN, FNP-C,...
11/21/2024
Oncology Learning Network APP Institute
Conference Coverage
Amivantamab Plus Chemotherapy Prolongs Survival, Post-Progression Outcomes for Patients With Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
11/20/2024
Stephanie Holland
According to second interim analysis results from the MARIPOSA-2 trial, amivantamab plus chemotherapy improved survival and post-progression outcomes compared to chemotherapy alone among patients with EGFR-mutated advanced non-small cell lung...
According to second interim analysis results from the MARIPOSA-2 trial, amivantamab plus chemotherapy improved survival and post-progression outcomes compared to chemotherapy alone among patients with EGFR-mutated advanced non-small cell lung...
According to second interim...
11/20/2024
Oncology Learning Network APP Institute
Research Review
The Enduring Benefit of Abemaciclib Plus Endocrine Therapy for Patients With HR-Positive, HER2-Negative High-Risk, Early Breast Cancer
11/20/2024
Allison Casey
According to the preplanned overall survival interim analysis from the phase 3 monarchE trial, abemaciclib plus endocrine therapy continues to show benefit for patients with HR-positive, HER2-negative high-risk early breast cancer.
According to the preplanned overall survival interim analysis from the phase 3 monarchE trial, abemaciclib plus endocrine therapy continues to show benefit for patients with HR-positive, HER2-negative high-risk early breast cancer.
According to the preplanned...
11/20/2024
Oncology Learning Network APP Institute
Conference Coverage
Implementation of an IV Push Policy for Antibiotic Administration Within An Oncology Urgent Care Clinic
11/18/2024
Allison Casey
Introduction of an IV push policy at an oncology urgent care clinic, led by an advanced practice provider, resulted in increased timely administration of antibiotics prior to hospitalization and a decrease in room dwell time.
Introduction of an IV push policy at an oncology urgent care clinic, led by an advanced practice provider, resulted in increased timely administration of antibiotics prior to hospitalization and a decrease in room dwell time.
Introduction of an IV push...
11/18/2024
Oncology Learning Network APP Institute
Conference Coverage
Workload Index Proves Valuable in Optimizing Oncology Advanced Practitioner Resourcing
11/18/2024
Janelle Bradley
Findings demonstrate the success of the workload index in supporting daily and longitudinal staffing needs as well as for operational and strategic planning and has improved advanced practitioner morale by demonstrating productivity not...
Findings demonstrate the success of the workload index in supporting daily and longitudinal staffing needs as well as for operational and strategic planning and has improved advanced practitioner morale by demonstrating productivity not...
Findings demonstrate the success...
11/18/2024
Oncology Learning Network APP Institute
Alrlene Siefker-Radke
Conference Coverage
Beyond Platinum: Current Treatment Approaches for Advanced Bladder Cancer
11/15/2024
Arlene Siefker-Radtke, MD, provides an overview on the current treatment landscape for patients with advanced bladder cancer.
Arlene Siefker-Radtke, MD, provides an overview on the current treatment landscape for patients with advanced bladder cancer.
Arlene Siefker-Radtke, MD,...
11/15/2024
Oncology Learning Network APP Institute
Conference Coverage
Weekend Infusion Model Reduces Emergency Department Visits and Length of Stay for Oncology Patients
11/14/2024
Gina Tomaine
The expansion of infusion services to a weekend-inclusive model led to less emergency department visits, saved inpatient days, and reduced hospital length of stay for oncology patients, according to data presented at the 2024 JADPRO meeting.
The expansion of infusion services to a weekend-inclusive model led to less emergency department visits, saved inpatient days, and reduced hospital length of stay for oncology patients, according to data presented at the 2024 JADPRO meeting.
The expansion of infusion...
11/14/2024
Oncology Learning Network APP Institute
Conference Coverage
New Patient Visits Via Telehealth Improve Management of Patients With MGUS at Increased Risk for Hematological Cancers
11/14/2024
Stephanie Holland
Conducting new patient visits via telehealth with advanced practice providers allows for quicker identification, assessment, and surveillance of patients with monoclonal gammopathy of undetermined significance (MGUS) at increased risk of...
Conducting new patient visits via telehealth with advanced practice providers allows for quicker identification, assessment, and surveillance of patients with monoclonal gammopathy of undetermined significance (MGUS) at increased risk of...
Conducting new patient visits...
11/14/2024
Oncology Learning Network APP Institute
Lorraine Drapek, Massachusetts General Hospital
Videos
The Impact of Radiation Therapy: Navigating Acute and Long-Term Side Effects
11/28/2023
Lorraine Drapek, DNP, FNP-BC
Lorraine Drapek, DNP, FNP-BC, AOCNP, discusses common side effects from radiation therapy and provides guidance on managing these side effects for optimal patient care.
Lorraine Drapek, DNP, FNP-BC, AOCNP, discusses common side effects from radiation therapy and provides guidance on managing these side effects for optimal patient care.
Lorraine Drapek, DNP, FNP-BC,...
11/28/2023
Oncology Learning Network APP Institute
Beth Finley-Oliver and Rachid Baz, Moffitt Cancer Center
Clinical Pearls
Individualizing Care for Multiple Myeloma: Navigating Treatment Options and Addressing Patient Needs
11/27/2023
Elizabeth Finley-Oliver, ARNP, MSN; Rachid Baz, MD
Elizabeth Finley-Oliver, MSN, ARNP, AGNP-BC, and Rachid Baz, MD, discuss the treatment landscape for patients with multiple myeloma and how clinicians can individualize care while addressing patient needs.
Elizabeth Finley-Oliver, MSN, ARNP, AGNP-BC, and Rachid Baz, MD, discuss the treatment landscape for patients with multiple myeloma and how clinicians can individualize care while addressing patient needs.
Elizabeth Finley-Oliver, MSN,...
11/27/2023
Oncology Learning Network APP Institute
Lorinda Coombs
APP Perspectives
Myeloma Care: Patient and Advanced Practice Provider Perspectives
11/17/2023
Lorinda Coombs, PhD, CNS, FNP-BC
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS,...
11/17/2023
Oncology Learning Network APP Institute

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use